Treatment of thyroid disorders before conception and in early pregnancy: A systematic review

Human Reproduction Update

Volumn 18, Issue 4, 2012, Pages 360-373

  Vissenberg, R ^a   van den boogaard, E ^a   van wely, M ^a   van der post, J A ^a   Fliers, E ^a   Bisschop, P H ^a   Goddijn, M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adverse pregnancy outcome; Hyperthyroidism; Hypothyroidism; Levothyroxine; Thyroid autoimmunity

Indexed keywords

LEVOTHYROXINE; PROPYLTHIOURACIL; THIAMAZOLE;

AUTOIMMUNITY; CLINICAL HYPOTHYROIDISM; COCHRANE LIBRARY; CONCEPTION; EMBASE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LOW BIRTH WEIGHT; MEDLINE; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; SUBCLINICAL HYPOTHYROIDISM; SYSTEMATIC REVIEW; THYROID AUTOIMMUNITY; THYROID DISEASE; TREATMENT OUTCOME;

ABORTION, SPONTANEOUS; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PRE-ECLAMPSIA; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH;

EID: 84863467332     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dms007     Document Type: Review

References (54)

1. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002;12:63-68.
2. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007;92:S1-47.
3. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011;17:456-520.
4. Baid SK, Merke DP. Aplasia cutis congenita following in utero methimazole exposure. J Pediatr Endocrinol Metab 2007;20:585-586.
5. Ball R, Freedman DB, Holmes JC, Midgley JE, Sheehan CP. Low-normal concentrations of free thyroxin in serum in late pregnancy: physiological fact, not technical artefact. Clin Chem 1989;35:1891-1896.
6. Behrooz HG, Tohidi M, Mehrabi Y, Behrooz EG, Tehranidoost M, Azizi F. Subclinical hypothyroidism in pregnancy: intellectual development of offspring. Thyroid 2011; 21:1143-1147.
7. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, van der Wal MF, Bonsel GJ. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol (Oxf) 2007;66:765-770.
8. Blazer S, Moreh-Waterman Y, Miller-Lotan R, Tamir A, Hochberg Z. Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol 2003;102:232-241.
9. Bolz M, Nagel H. Pregnancy associated with congenital aplasia of thyroid gland- case report under special consideration of aspects of maternal hypothyroidism. Zentralblatt fur Gynakologie 1994;116:515-521.
10. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-534.
11. Chen CH, Xirasagar S, Lin CC, Wang LH, Kou YR, Lin HC. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011;118:1365-1373.
12. Clementi M, Di GE, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999;83:43-46.
13. Clementi M, Di GE, Cassina M, Leoncini E, Botto LD, Mastroiacovo P. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010; 95:E337-E341.
14. Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009;94:1881-1882.
15. Di GE, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A et al. Adverse effects of prenatal methimazole exposure. Teratology 2001;64:262-266.
16. Diez-Delgado RJ, Belmonte Martin MJ, Calvo Bonachera MD, Lopez CE. Aplasia cutis as a teratogenic effect of methimazole. An Esp Pediatr 1999;51:290-292.
17. Dutertre JP, Jonville AP, Moraine C, Autret E. Aplasia cutis after exposure to carbimazole in utero. J Gynecol Obstet Biol Reprod 1991;20:575-576.
18. Earl R, Crowther CA, Middleton P. Interventions for preventing and treating hyperthyroidism in pregnancy. Cochrane Database Syst Rev 2010; CD008633.
19. Fitzpatrick DL, Russell MA. Diagnosis and management of thyroid disease in pregnancy. Obstet Gynecol Clin North Am 2010;37:173-193.
20. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-555.
21. Higgins J, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. In the Cochrane Collaboration 2 (ed), 2012.
22. Idris I, Srinivasan R, Simm A, Page RC. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf) 2005;63:560-565.
23. Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2011;95:1650-1654.
24. Klein RZ, Sargent JD, Larsen PR, Waisbren SE, Haddow JE, Mitchell ML. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen 2001;8:18-20.
25. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702-755.
26. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993;81:349-353.
27. Li Y, Shan Z, Teng W, Yu X, Li Y, Fan C, Teng X, Guo R, Wang H, Li J et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf) 2010;72:825-829.
28. Matalon S, Sheiner E, Levy A, Mazor M, Wiznitzer A. Relationship of treated maternal hypothyroidism and perinatal outcome. J Reprod Med 2006;51:59-63.
29. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994;84:946-949.
30. Momotani N, Ito K, Hamada N. Maternal hyperthyroidism and congenital malformation in the offspring. Clinical Endocrinology 1984;20:695-700.
31. Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997;82:3633-3636.
32. Negro R, Mangieri T, Coppola L, Presicce G, Casavola EC, Gismondi R, Locorotondo G, Caroli P, Pezzarossa A, Dazzi D et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 2005;20:1529-1533.
33. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587-2591.
34. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007;92:1263-1268.
35. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010; 95:1699-1707.
36. Nohr SB, Jorgensen A, Pedersen KM, Laurberg P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrinol Metab 2000;85:3191-3198.
37. Oxford Centre for Evidence-Based Medicine. Levels of Evidence. March 2009. http://www.cebm.net/?o=1116 (28 July 2011, date last accessed).
38. Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem 2001;38:329-332.
39. Phuapradit W, Saropala N, Rajatanavin R, Hotrakit S. Graves' disease complicating pregnancy. J Med Assoc Thai 1993;76:380-384.
40. Rasmussen SA, Yazdy MM, Carmichael SL, Jamieson DJ, Canfield MA, Honein MA. Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 2007; 110:369-377.
41. Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev 2010; CD007752.
42. Revelli A, Casano S, Piane LD, Grassi G, Gennarelli G, Guidetti D, Massobrio M. A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reprod Biol Endocrinol 2009;7:137.
43. Rivkees SA, Mattison DR. Propylthiouracil (PTU) hepatotoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009; 2009:132041.
44. Rosenfeld H, Ornoy A, Shechtman S, Diav-Citrin O. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 2009;68:609-617.
45. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340: c332.
46. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S et al. Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081-1125.
47. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011;342:d2616.
48. U.S. Preventing Task Force Ratings: Strengths of Recommendations and Quality of Evidence. Guide to Clinical Preventive Services, 3rd edn. Periodic updates 2000-2003, 2003.
49. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, Bilous R. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007;92:203-207.
50. Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, Negro R, Vermiglio F, Poppe K. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol 2012;166:49-54.
51. van den Boogaard E, Vissenberg R, Land JA, van WM, van der Post JA, Goddijn M, Bisschop PH. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update, 2011;17:605-619.
52. von EE, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-808.
53. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 1994;170:90-95.
54. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999;9:727-733.